LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 118 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $53,801,000 | 3.88% |
| Defender Capital, LLC. | 5,006,185 | $7,983,000 | 2.78% |
| Raffles Associates | 1,306,095 | $2,011,000 | 2.07% |
| Prescott General Partners LLC | 1,851,851 | $2,852,000 | 0.13% |
| Aristides Capital LLC | 100,000 | $154,000 | 0.09% |
| DAFNA Capital Management LLC | 140,000 | $216,000 | 0.06% |
| Long Focus Capital Management, LLC | 215,000 | $331,000 | 0.04% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $70,000 | 0.04% |
| DCF Advisers, LLC | 53,000 | $82,000 | 0.04% |
| Fort Sheridan Advisors LLC | 75,931 | $117,000 | 0.03% |